Why the study?
Does a one-time instillation of triamcinolone hexacetonide after pericardiocentesis improve symptoms and prevent recurrence in patients with dialysis-associated pericardial effusion?
Does a one-time instillation of triamcinolone hexacetonide after pericardiocentesis improve symptoms and prevent recurrence in patients with dialysis-associated pericardial effusion?
Intrapericardial instillation of triamcinolone hexacetonide after pericardiocentesis appears safe and effective for treating dialysis-associated pericardial effusion, potentially avoiding the need for prolonged drainage or surgery.
Answers are grounded in this paper and cite their sources.
Supports intrapericardial triamcinolone after pericardiocentesis in dialysis effusion; hypothesis-generating and should not change practice without randomized data.
Five patients receiving maintenance hemodialysis for end-stage renal disease underwent therapeutic pericardiocentesis for pericarditis manifested by either cardiac tamponade or effusion unresponsive to conservative therapy. Pericardiocentesis was followed by a one-time instillation of triamcinolone hexacetonide, a nonabsorbable corticosteroid, into the pericardial space with subsequent needle withdrawal. All patients had prompt hemodynamic and symptomatic improvement. Serial echocardiograms showed resolution of the pericardial effusion in all patients. Follow-up evaluation for six months to six years has shown no clinical or postmortem evidence of recurrence. This procedure appears safe and effective and potentially can obviate the need for prolonged catheter drainage or more invasive surgical procedures as therapy for these patients.
No takes yet. Share an insight, caveat, or question.
Richard J. Quigg (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: